Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trialsfor Breast Cancer, NOS347 locations incl. FairbanksSponsor: Eastern Cooperative Oncology GroupSex: All·Age: 18 - 39Code: NCT05108298·RecruitingApply to this trial
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)for Malignant Solid Neoplasm384 locations incl. AnchorageSponsor: ECOG-ACRIN Cancer Research GroupSex: All·Age: All ages·Accepts healthy volunteersCode: NCT06295367·RecruitingApply to this trial
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemiafor B Acute Lymphoblastic Leukemia455 locations incl. BirminghamSponsor: Alliance for Clinical Trials in OncologySex: All·Age: 18 - 39Code: NCT03150693·Phase 3·RecruitingApply to this trial
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutationfor Pancreatic Acinar Cell CarcinomaDrug: Olaparib451 locations incl. DaytonSponsor: National Cancer Institute (NCI)Sex: All·Age: 18+Code: NCT04858334·Phase 2·RecruitingApply to this trial
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trialfor Metastatic Clear Cell Renal Cell Carcinoma387 locations incl. BirminghamSponsor: SWOG Cancer Research NetworkSex: All·Age: 18+Code: NCT04510597·Phase 3·RecruitingApply to this trial
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancerfor Castration Levels of Testosterone334 locations incl. GilbertSponsor: SWOG Cancer Research NetworkSex: Male·Age: 18+Code: NCT03678025·Phase 3·RecruitingApply to this trial
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemiafor B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative276 locations incl. BirminghamSponsor: National Cancer Institute (NCI)Sex: All·Age: 18+Code: NCT03739814·Phase 2·RecruitingApply to this trial
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)for Recurrent T Acute Lymphoblastic Leukemia163 locations incl. BirminghamSponsor: SWOG Cancer Research NetworkSex: All·Age: 12+Code: NCT04315324·Phase 1, Phase 2·RecruitingApply to this trial
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcomafor Metastatic Malignant Neoplasm in the Lung219 locations incl. BirminghamSponsor: Children's Oncology GroupSex: All·Age: Up to 50Code: NCT05235165·Phase 3·RecruitingApply to this trial
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)for Down SyndromeDrug: Nivolumab209 locations incl. BirminghamSponsor: National Cancer Institute (NCI)Sex: All·Age: 1 - 30Code: NCT04546399·Phase 2·RecruitingApply to this trial
Collection and Storage of Tissue and Blood Samples From Patients With Cancerfor Hematopoietic and Lymphatic System Neoplasm140 locations incl. BirminghamSponsor: National Cancer Institute LAOSex: All·Age: 2 Months+Code: NCT02474160·RecruitingApply to this trial
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesotheliomafor Pleural Biphasic Mesothelioma132 locations incl. AnchorageSponsor: Alliance for Clinical Trials in OncologySex: All·Age: 18+Code: NCT05647265·Phase 2·RecruitingApply to this trial